myeloproliferative neoplasms (MPN) | Aplastic Anemia & MDS International Foundation

myeloproliferative neoplasms (MPN)

Nikolai Podoltsev, MD, PhD

Podoltsev, Nikolai
Associate Director of the Hematology/Oncology Fellowship Program
Smilow Cancer Hospital at Yale

Dr. Podoltsev practice is focused on myeloid neoplasms including acute myelogenous leukemias (AML), myelodisplastic syndromes (MDS), myeloproliferative neoplasms (MPNs) like polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), chronic myelogenous leukemia (CML) among others. He is providing care for patients with

Thomas Prebet, MD, PhD

Prebet, Thomas
Medical Director of Hematology and Cell Therapy
Smilow Cancer Hospital at Yale

After completing his doctorate in medical hematology and oncology in Lyon, France, Dr. Prebet joined Institut Paoli-Calmettes in Marseille, France and completed a fellowship in Johns Hopkins University (Baltimore, MA, USA) as a Fullbright alumni. Dr. Prebet is currently the director of the inpatient hematology unit and the medical director of the hematology division of Yale

2020 National Patient & Family Conference (virtual)

AAMDSIF is hosting the 2020 National Patient & Family Conference ONLINE over three days, July 17 - 19, 2020. The Conference will feature three days of educational workshops, interesting speakers and support groups for patients with

Save the date!
Event Date: 
Fri, 07/17/2020 to Sun, 07/19/2020

Catriona Jamison, MD, PhD

Jamison, Catriona
Professor of Medicine
Moores Cancer Center

Catriona Jamieson, MD, PhD, is a board-certified hematologist with broad clinical expertise in caring for patients with hematologic malignancies. As hematology team leader for the Division of Hematology/Oncology at UC San Diego Health Moores Cancer Center, Dr.

omparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

This phase II trial studies how well 3 different drug combinations prevent graft versus host disease (GVHD) after donor stem cell transplant. Calcineurin inhibitors, such as

National Conference 2020 Virtual March for Marrow

We've gone VIRTUAL!
In light of the spread of the Coronavirus (COVID-19) and with the health and well-being of our patients, family members, friends and faculty as our top priority, AAMDSIF has decided to hold our March for Marrow as a VIRTUAL WALK! 

Event Date: 
Sat, 07/18/2020
Community Event Type: 

Barry Skikne, MD

Skikne, Barry
Hematologist
Westwood Medical Pavilion and the Richard and Annette Bloch Cancer Care Pavilion

Dr. Barry Skikne is certified by the American Board of Internal Medicine with a subcertification in hematology. He completed a fellowship at the University of Kansas Medical Center. He earned his medical degree from the University of Witwatersrand and completed his residency at Johannesburg Hospital.